Open NowResearch

Cochrane Funding Program 2026

National Health and Medical Research Council (NHMRC) · Australia

The Cochrane Funding Program 2026 provides Australian Government funding to support Cochrane activities in Australia over four years. It aims to support Australian Cochrane review production and evidence synthesis to inform healthcare decision making and deliver high-value outputs.

Funding

Up to $6.5M

Deadline

1 May 2026

Duration

up to 4 years

Location

Australia

Who Can Apply

NHMRC approved Administering Institutions only Only available to Cochrane Australia Applications must meet all requirements in the Cochrane Funding 2026 Grant Guidelines
Applications will only be accepted from NHMRC approved Administering Institutions. Applications must satisfy all the requirements set out in the Cochrane Funding 2026 Grant Guidelines. This grant is only available to Cochrane Australia.

What's Funded

Production of Cochrane systematic reviews, evidence synthesis, and related activities that support evidence-based healthcare decision making, research translation, and use of new tools and technologies including artificial intelligence in health.

Expected Outcomes

Australian Cochrane review production and evidence synthesis outputs to inform healthcare decision making, with grants announced in July 2026 and research outputs delivered for up to four years from commencement.

Key Information

Applicant Types

universityother

Stage

any

Funding Purposes

researchcommunityother

Keywords

Cochranemedical researchsystematic reviewsevidence synthesishealthcare decision makingresearch translationclinical healthcareartificial intelligence in health

Frequently Asked Questions

What is the Cochrane Funding Program 2026?

The Cochrane Funding Program 2026 is a research grant offered by National Health and Medical Research Council (NHMRC) in Australia, providing Up to $6.5M in funding. The Cochrane Funding Program 2026 provides Australian Government funding to support Cochrane activities in Australia over four years. It aims to support Australian Cochrane review production and evidence synthesis to inform healthcare decision making and deliver high-value outputs.

How much funding does the Cochrane Funding Program 2026 provide?

The Cochrane Funding Program 2026 provides Up to $6.5M in funding. The typical project duration is up to 4 years.

Who is eligible for the Cochrane Funding Program 2026?

NHMRC approved Administering Institutions only Only available to Cochrane Australia Applications must meet all requirements in the Cochrane Funding 2026 Grant Guidelines

When does the Cochrane Funding Program 2026 close?

Applications close on 1 May 2026.

What activities are funded?

Production of Cochrane systematic reviews, evidence synthesis, and related activities that support evidence-based healthcare decision making, research translation, and use of new tools and technologies including artificial intelligence in health.

How do I apply for the Cochrane Funding Program 2026?

Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.

Need help applying?

Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.